Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
在 HR+/HER2- 晚期乳腺癌女性患者中,帕博西尼联合氟维司群治疗的总生存期:PALOMA-3 双盲 III 期随机研究的最新探索性分析
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0305
Cristofanilli, Massimo; Rugo, Hope S; Im, Seock-Ah; Slamon, Dennis J; Harbeck, Nadia; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Iwata, Hiroji; O'Leary, Ben; André, Fabrice; Loibl, Sibylle; Bananis, Eustratios; Liu, Yuan; Huang, Xin; Kim, Sindy; Lechuga Frean, Maria Jose; Turner, Nicholas C